Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jason Beverley
Observed name:
Beverley, Jason
Institution:
San Francisco Department of Public Health
Observed institutions:
Centers for Disease Control and Prevention,
Government of the District of Columbia,
San Francisco Department of Public Health,
District of Columbia Department of Health,
Epidemic Intelligence Service,
Howard County Health Department,
Indiana University School of Medicine
show all 7
ORCID:
0000-0001-7593-8923
Observed ORCID:
0000-0001-7593-8923
OpenAlex ID:
A5021222923
Epidemiologic and Clinical Features of Children and Adolescents Aged <18 Years with Monkeypox — United States, May 17–September 24, 2022
2022
·
Ian Hennessee
, Victoria Shelus
, et al.
·
MMWR Morbidity and Mortality Weekly Report
·
65
PDF
Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox — United States, 2022
2022
·
Faisal S. Minhaj
, Julia K. Petras
, et al.
·
MMWR Morbidity and Mortality Weekly Report
·
42
PDF
Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.
2022
·
Rachel K. Scott
, Shawnika J. Hull
, et al.
·
Archives of Sexual Behavior
·
24
Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City
2023
·
Rachel K. Scott
, Shawnika J. Hull
, et al.
·
Women s Health Issues
·
20
PDF
Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic
2023
·
Rachel K. Scott
, Megan Deyarmond
, et al.
·
AIDS Patient Care and STDs
·
19
Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.)
2024
·
Isabel Griffin
, Isha Berry
, et al.
·
Vaccine
·
7
Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.C.
2024
·
Jennifer L. Zack
, Shawnika J. Hull
, et al.
·
Therapeutic Advances in Infectious Disease
·
4
Routine Pharyngeal Gonorrhea Test of Cure: Is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?
2025
·
Laura A. S. Quilter
, Rebekah Horowitz
, et al.
·
Sexually Transmitted Diseases
·
3
Predictors of PrEP Retention and Attrition in an Urban Publicly Funded Safety-net Specialty Clinic
2024
·
Kate Drezner
, Megan Coleman
, et al.
·
AIDS and Behavior
·
3
PDF
Show more works
View as search
Works count:
11
Citation count:
187
H-index:
6
I10-index:
5
Year
Topic
Type